Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3196549

Documents

Beta release

Statistics of DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosing
Statistics for this year
PeriodVisitsDownloads
20241111
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0800
2024-0911
2024-1000